Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia

Clinical Journal of Pain

Volumn 22, Issue 1, 2006, Pages 32-36

  Pöyhiä, Reino ^a,b   Vainio, Anneli ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Allodynia; Capsaicin; Hyperalgesia; Ketamine gel; Volunteer

Indexed keywords

CAPSAICIN; KETAMINE; PLACEBO; ANESTHETIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ALLODYNIA; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; COTTON; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DYSESTHESIA; FOREARM; HEAD; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MICROFILAMENT; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIZATION; TACTILE STIMULATION; VISUAL ANALOG SCALE; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; MALE; METHODOLOGY; MIDDLE AGED; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; ANALYSIS OF VARIANCE; ANESTHETICS, DISSOCIATIVE; AREA UNDER CURVE; CAPSAICIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPERALGESIA; KETAMINE; MALE; MIDDLE AGED; PAIN MEASUREMENT; TIME FACTORS;

EID: 33644912355     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000149800.39240.95     Document Type: Article

References (39)

1. Bennett GJ. Update on the neurophysiology of pain: transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage. 2000;19:S2-S6.
2. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48:1212-1218.
3. Rabben T, Skjellbred P, Oye I. Prolonged effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999;289:1060-1066.
4. Haines DR, Gaines SP. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. Pain. 1999;83:283-287.
5. Carlton SM, Coggeshall RE. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res. 1999;820:63-70.
6. Carlton SM, Zhou S, Coggeshall RE. Evidence for the interaction of glutamate and NK1 receptor in the periphery. Brain Res. 1998;790:160-169.
7. Davidson EM, Coggeshall RE, Carlton SM. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport. 1997;8:941-946.
8. Liu XJ, White TD, Sawynok J. Intraplantar injection of glutamate evokes peripheral adenosine release in the rat hind paw: involvement of peripheral ionotropic glutamate receptors and capsaicin-sensitive sensory afferents. J Neurochem. 2002;80:562-570.
9. Oatway M, Reid A, Sawynok J. Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg. 2003;97:168-173.
10. Warncke T, Jorum E, Stubhaug A. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett. 1997;227:1-4.
11. Koppert W, Zeck S, Blunk JA, et al. The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction. Anesth Analg. 1999;89:1521-1527.
12. Pedersen JL, Galle TS, Kehlet H. Peripheral analgesic effects of ketamine in acute inflammatory pain. Anesthesiology. 1998;89:58-66.
13. Gottrup H, Bach FW, Arendt-Nielsen L, et al. Peripheral lidocaine but not ketamine inhibits capsaicin-induced hyperalgesia in humans. Br J Anaesth. 2000;85:520-528.
14. Crowley KL, Flores JA, Hughes CN, et al. Clinical application of ketamine in the treatment of neuropathic pain. Int J Pharm Compound. 1998;2:122-127.
15. Quann D, Wellish M, Gilden DH. Topical ketamine treatment of postherpetic neuralgia. Neurology. 2003;60:1391.
16. Ushida T, Tani T, Kanbara T, et al. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type I. Reg Anesth Pain Med. 2002;27:524-528.
17. Azevedo V, Lauretti G, Pereira NL, et al. Transdermal ketamine as an adjuvant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockade. Anesth Analg. 2000;91:1479-1482.
18. Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003;19:323-328.
19. Liu M, Max MB, Robinovitz E, et al. The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction. J Pain Symptom Manage. 1998;16:10-20.
20. Afrah AW, Stiller CO, Olgart L, et al. Involvement of spinal N-methyl-D-aspartate receptors in capsaicin-induced in vivo release of substance P in the rat dorsal horn. Neurosci Lett. 2001;316:83-86.
21. Palazzo E, de Novellis V, Marabese I, et al. Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur J Pharmacol. 2002;439:69-75.
22. Park KM, Max MB, Robinovitz E, et al. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia and allodynia produced by intradermal capsaicin in human subjects. Pain. 1995;63:163-172.
23. Andersen OK, Felsby S, Nikolajsen L, et al. The effect of ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin - a double-blind, placebo-controlled, human experimental study. Pain. 1996;68:51-62.
24. Hughes A, Macleod A, Growcott J, et al. Assessment of the reproducibility of intradermal administration of capsaicin as a model for inducing human pain. Pain. 2002;99:323-331.
25. Liu M, Max MB, Robinovitz E, et al. The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction. J Pain Symptom Manage. 1998;16:10-20.
26. Ali Z, Meyer RA, Campbell JN. Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin. Pain. 1996;68:401-411.
27. Davidson EM, Coggeshall RE, Carlton SM. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport. 1997;8:941-946.
28. Arhem P, Rydqvist B. The mechanism of action of ketamine on the myelinated nerve membrane. Eur J Pharmacol. 1986;126:245-251.
29. Shrivastav BB. Mechanism of ketamine block of nerve conduction. J Pharmacol Exp Ther. 1977;201:162-170.
30. Wagner LE 2nd, Gingrich KJ, Kulli JC, et al. Ketamine blockade of voltage gated sodium channels: evidence for a shared receptor site with local anesthetics. Anesthesiology. 2001;95:1406-1413.
31. Rieckziegel G, Friedrich P, Urban PW. Ketamine effects on human neuronal Na+ channels. Eur J Anaesthesiol. 2002;19:634-640.
32. Sawynok J, Reid A. Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats. Pain. 2003;102:179-186.
33. Pfenniger EG, Durieux ME, Himmelseher S. Cognitive impairment after small-dose ketamine isomers in comparisons to equianalgesic racemic ketamine in human volunteer. Anesthesiology. 2002;96:357-366.
34. Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth. 1981;53:805-810.
35. Leung A, Wallace MS, Ridgeway B, et al. Comparison-effect relationship of intravenous and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain. 2001;91:177-187.
36. Wallace MS, Ridgeway B, Leung A, et al. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia. J Clin Pharmacol. 2002;42:70-80.
37. Treede RD, Meyer RA, Raja SN, et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;38:397-421.
38. LaMotte RH, Shain CS, Simone DA, et al. Neurogenic hyperalgesia: psychophysical studies of undelying mechanisms. J Neurophysiol. 1991;66:190-211.
39. Kilo S, Schmelz M, Koltzenburg M, et al. Different patterns of hyperalgesia induced by experimental inflammation in human skin. Brain. 1994;117:385-396.